As AR and Myc are critical to the regulation of cell survival and proliferation in prostate cancer, we assessed the time course by which they are suppressed upon fimepinostat treatment in the 22Rv1 and LNCaP95 cell lines. The gene discussed is AR; the disease is Familial prostate cancer.